{"type":"article","id":16217,"title":"中国仿制版瑞德西韦将在意大利开展临床试验（大意）","uid":41163,"topics":[5812,6783,6489],"contents":"<a href=\"https://www.abruzzolive.tv/salute/coronavirus-a-chieti-si-sperimenta-nuovo-farmaco-it26348.html\" rel=\"nofollow noreferrer noopener\" target=\"_blank\">https://www.abruzzolive.tv/salute/coronavirus-a-chieti-si-sperimenta-nuovo-farmaco-it26348.html</a><br>\n<br>\n因为原文是意大利文我不懂，只能用Google翻成英文看个大意，就是意大利的Chieti hospital将开展用瑞德西韦治疗新冠病人的临床试验。另外文章提到了他们之前用Tocilizumab（托珠单抗）治疗新冠的效果不错。<br>\n<br>\n不太懂药物的专利法，但即使是合法仿制，这个吃相也太难看了吧。<br>\n<br>\n网上有人提到浙江新冠致死率低很可能和此药有关，希望是真的。<br>\n<br>\n其它有关瑞德西韦疗效的新闻：<br>\n<br>\n<a href=\"https://m.jiemian.com/article/4113713.html\" rel=\"nofollow noreferrer noopener\" target=\"_blank\">https://m.jiemian.com/article/4113713.html</a>","date":"2020-03-15","agreeCount":0,"discussionCount":0}